secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2023-05-17T23:59:59+00:00
Accession:  0001628280-23-018514
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Better Choice names Kent Cunningham as CEO; Conacher steps down as interim CEO
------------------------------------------------------------------------------

- Lionel Conacher resigns as interim CEO effective May 22, 2023, remains on Board as director.
- Kent Cunningham appointed CEO effective May 22, 2023; previously a Principal at Catapult Consulting.
- Cunningham receives $350,000 base salary, annual bonus target of 50% of base (50% cash, 50% stock).
- Initial grant of 1,000,000 RSUs with three-year vesting tied to stock price thresholds ($1.00, $2.00, $2.50).
- RSUs vest 33.3% per year if stock price targets met; forfeited if time/performance conditions not satisfied.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000162828023018514/0001628280-23-018514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000162828023018514/bttr-20230516.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-018514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer